Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood (Englisch)
- Neue Suche nach: Kristensen, Thomas
- Neue Suche nach: Broesby-Olsen, Sigurd
- Neue Suche nach: Vestergaard, Hanne
- Neue Suche nach: Bindslev-Jensen, Carsten
- Neue Suche nach: Mortz, Charlotte Gotthard
- Neue Suche nach: Kjaer, Henrik Fomsgaard
- Neue Suche nach: Møller, Michael Boe
- Neue Suche nach: Kristensen, Thomas
- Neue Suche nach: Broesby-Olsen, Sigurd
- Neue Suche nach: Vestergaard, Hanne
- Neue Suche nach: Bindslev-Jensen, Carsten
- Neue Suche nach: Mortz, Charlotte Gotthard
- Neue Suche nach: Kjaer, Henrik Fomsgaard
- Neue Suche nach: Møller, Michael Boe
In:
Leukemia & Lymphoma
;
60
, 1
;
268-270
;
2019
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood
-
Beteiligte:Kristensen, Thomas ( Autor:in ) / Broesby-Olsen, Sigurd ( Autor:in ) / Vestergaard, Hanne ( Autor:in ) / Bindslev-Jensen, Carsten ( Autor:in ) / Mortz, Charlotte Gotthard ( Autor:in ) / Kjaer, Henrik Fomsgaard ( Autor:in ) / Møller, Michael Boe ( Autor:in ) / on behalf of the Mastocytosis Centre Odense University Hospital (MastOUH)
-
Erschienen in:Leukemia & Lymphoma ; 60, 1 ; 268-270
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:02.01.2019
-
Format / Umfang:3 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 60, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
LeukeMYC prognosticationKnorr, Katherine L. B. / Tallman, Martin S. et al. | 2019
- 3
-
A renaissance for autologous transplantation in follicular lymphoma?Chaekal, Ok-Kyong / van Besien, Koen et al. | 2019
- 6
-
Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapiesSethi, Tarsheen K. / Reddy, Nishitha M. et al. | 2019
- 19
-
Hemophagocytic lymphohistiocytosis in adultsBhatt, Neel S. / Oshrine, Benjamin / An Talano, Julie et al. | 2019
- 29
-
Extracellular vesicles in hematological malignanciesLitwińska, Zofia / Łuczkowska, Karolina / Machaliński, Bogusław et al. | 2019
- 37
-
MYC protein expression is an important prognostic factor in acute myeloid leukemiaOhanian, Maro / Rozovski, Uri / Kanagal-Shamanna, Rashmi / Abruzzo, Lynne V. / Loghavi, Sanam / Kadia, Tapan / Futreal, Andrew / Bhalla, Kapil / Zuo, Zhuang / Huh, Yang O. et al. | 2019
- 49
-
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine careBell, Jill A. / Galaznik, Aaron / Blazer, Marlo / Farrelly, Eileen / Ogbonnaya, Augustina / Raju, Aditya / Eaddy, Michael / Fram, Robert J. / Faller, Douglas V. et al. | 2019
- 60
-
Daunorubicin during delayed intensification decreases the incidence of infectious complications – a randomized comparison in trial CoALL 08-09Schramm, Franziska / Zimmermann, Martin / Jorch, Norbert / Pekrun, Arnulf / Borkhardt, Arndt / Imschweiler, Thomas / Christiansen, Holger / Faber, Jörg / Feuchtinger, Tobias / Schmid, Irene et al. | 2019
- 69
-
AML: high serum ferritin at initial diagnosis has a negative impact on long-term survivalIhlow, Jana / Gross, Sophia / Sick, Annabel / Schneider, Tanja / Flörcken, Anne / Burmeister, Thomas / Türkmen, Seval / Arnold, Renate / Dörken, Bernd / Westermann, Jörg et al. | 2019
- 78
-
Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapyKrull, Kathinka / Kunstreich, Marina / Bronsema, Annika / Bleckmann, Kirsten / Classen, Carl-Friedrich / Erdlenbruch, Bernhard / Jorch, Norbert / Kolb, Reinhard / Leipold, Alfred / Moser, Olga et al. | 2019
- 85
-
Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumabPermpalung, Nitipong / Mahoney, Monica V. / McCoy, Christopher / Atsawarungruangkit, Amporn / Gold, Howard S. / Levine, James D. / Wong, Michael T. / LaSalvia, Mary T. / Alonso, Carolyn D. et al. | 2019
- 92
-
A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*Chen, Christine I. / Paul, Harminder / Le, Lisa W. / Wei, Ellen N. / Snitzler, Susi / Wang, Trina / Levina, Olga / Kakar, Sumeet / Lau, Anthea / Queau, Michelle et al. | 2019
- 101
-
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survivalSpina, Francesco / Radice, Tommaso / De Philippis, Chiara / Soldarini, Martina / Di Chio, Maria Chiara / Dodero, Anna / Guidetti, Anna / Viviani, Simonetta / Corradini, Paolo et al. | 2019
- 110
-
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantationJain, Tania / Kosiorek, Heidi E. / Grys, Thomas E. / Kung, Shu Ting / Shah, Vishal S. / Betcher, Jeffrey A. / Slack, James L. / Leis, Jose F. / Khera, Nandita / Noel, Pierre et al. | 2019
- 118
-
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patientsJurczyszyn, Artur / Castillo, Jorge J. / Avivi, Irit / Czepiel, Jacek / Davila, Julio / Vij, Ravi / Fiala, Mark A. / Gozzetti, Alessandro / Grząśko, Norbert / Milunovic, Vibor et al. | 2019
- 124
-
Infectious complications in children treated for hodgkin and non-hodgkin lymphomas in polish pediatric leukemia/lymphoma study group: incidence, epidemiology and etiologyZajac-Spychala, Olga / Wachowiak, Jacek / Szmydki-Baran, Anna / Hutnik, Lukasz / Salamonowicz, Malgorzata / Matysiak, Michal / Czyzewski, Krzysztof / Wysocki, Mariusz / Zalas-Wiecek, Patrycja / Malas, Zofia et al. | 2019
- 133
-
Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real worldManna, Mita / Lee-Ying, Richard / Davies, Gwynivere / Stewart, Colin / Oh, Danielle H. / Peters, Anthea / Stewart, Douglas A. et al. | 2019
- 142
-
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantationRomero, Samuel / Montoro, Juan / Guinot, Marta / Almenar, Luis / Andreu, Rafael / Balaguer, Aitana / Beneyto, Isabel / Espí, Jordi / Gómez-Codina, José / Iacoboni, Gloria et al. | 2019
- 151
-
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysisWeisel, Katja / Sonneveld, Pieter / Spencer, Andrew / Beksac, Meral / Rizzo, Maria / Xu, Yingxin / Fahrbach, Kyle / Gaudig, Maren / Slavcev, Mary / Dearden, Lindsay et al. | 2019
- 163
-
Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myelomaKumar, Shaji / Durie, Brian / Nahi, Hareth / Vij, Ravi / Dimopoulos, Meletios A. / Kastritis, Efstathios / Terpos, Evangelos / Leleu, Xavier / Beksac, Meral / Goldschmidt, Hartmut et al. | 2019
- 172
-
Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 studyRobak, Tadeusz / Huang, Huiqiang / Jin, Jie / Zhu, Jun / Liu, Ting / Samoilova, Olga / Pylypenko, Halyna / Verhoef, Gregor / Siritanaratkul, Noppadol / Osmanov, Evgenii et al. | 2019
- 180
-
Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myelomaDimopoulos, Konstantinos / Fibiger Munch-Petersen, Helga / Winther Eskelund, Christian / Dissing Sjö, Lene / Ralfkiaer, Elisabeth / Gimsing, Peter / Grønbaek, Kirsten et al. | 2019
- 189
-
Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cellsGover-Proaktor, Ayala / Granot, Galit / Pasmanik-Chor, Metsada / Pasvolsky, Oren / Shapira, Saar / Raz, Oshrat / Raanani, Pia / Leader, Avi et al. | 2019
- 200
-
Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitorsErbilgin, Yucel / Eskazan, Ahmet Emre / Hatirnaz Ng, Ozden / Salihoglu, Ayse / Elverdi, Tugrul / Firtina, Sinem / Tasar, Orcun / Mercan, Sevcan / Sisko, Sinem / Khodzhaev, Khusan et al. | 2019
- 208
-
Clinical significance of HLA-E genotype and surface/soluble expression levels between healthy individuals and patients with acute leukemiaXu, Yun-Ping / Wieten, Lotte / Wang, Song-Xing / Cai, Yun / Olieslagers, Timo / Zhang, Li / He, Liu-Mei / Tilanus, Marce G. J. / Hong, Wen-Xu et al. | 2019
- 216
-
Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?Adehin, Ayorinde / Adeagbo, Babatunde A. / Kennedy, Martin A. / Bolaji, Oluseye O. / Olugbade, Tiwalade A. / Bolarinwa, Rahman A. / Durosinmi, Muheez A. et al. | 2019
- 222
-
Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patientsJamet, Bastien / Bailly, Clément / Carlier, Thomas / Planche, Lucie / Touzeau, Cyrille / Kraeber-Bodéré, Françoise / Moreau, Philippe / Bodet-Milin, Caroline et al. | 2019
- 226
-
A rare colonic manifestation of chronic lymphocytic leukemiaNamn, Yunseok / Furman, Richard R. / Crawford, Carl et al. | 2019
- 230
-
Rapid complete response to blinatumomab as a successful bridge to allogeneic stem cell transplantation in a case of refractory Richter syndromeAlderuccio, Juan Pablo / Mackrides, Nicholas / Chapman, Jennifer R. / Vega, Francisco / Lossos, Izidore S. et al. | 2019
- 234
-
BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patientsThan, Hein / Lye, Weng K. / Sng, Colin / Allen, John C.Jr / Ong, S. Tiong / Chuah, Charles et al. | 2019
- 238
-
Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studiesBertoli, Sarah / Tavitian, Suzanne / Berard, Emilie / Gadaud, Noemie / Luquet, Isabelle / Huynh, Anne / Sarry, Audrey / Huguet, Françoise / Récher, Christian et al. | 2019
- 242
-
Polyreactive antibodies in CLL correlate with the level of immunoglobulins not the number of B lymphocytesGunti, Sreenivasulu / Herman, Sarah E.M. / Gottumukkala, Raju V.S.R.K. / Xiong, Ying / Sun, Clare / Carmona, Gilberto N. / Wiestner, Adrian / Notkins, Abner L. et al. | 2019
- 246
-
Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemiaStahl, Maximilian / DeVeaux, Michelle / Montesinos, Pau / Itzykson, Raphaël / Ritchie, Ellen K. / Sekeres, Mikkael A. / Barnard, John / Podoltsev, Nikolai A. / Brunner, Andrew / Komrokji, Rami S. et al. | 2019
- 250
-
Location matters in early stage nodal diffuse large B-cell lymphomaLontos, Konstantinos / Tsagianni, Anastasia / Yuan, Jian-Min / Normolle, Daniel P. / Boyiadzis, Michael / Hou, Jing-Zhou / Swerdlow, Steven H. / Dorritie, Kathleen A. et al. | 2019
- 254
-
Complete remission of agranulocytosis after splenectomy in a variant form of T-cell large granular lymphocyte leukemiaLozano, Claire / Brun, Sophie / Arnaud, Anne / Gaulard, Philippe / Gonzalez, Samia / Crouzet, Julien / Gris, Jean-Christophe et al. | 2019
- 258
-
Prognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALLAmpatzidou, Maria / Paterakis, Georgios / Vasdekis, Vassilios / Papadhimitriou, Stephanos I. / Papadakis, Vassilios / Vassilopoulos, Georgios / Polychronopoulou, Sophia et al. | 2019
- 262
-
PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditionsPodszywalow-Bartnicka, Paulina / Maifrede, Silvia / Le, Bac Viet / Nieborowska-Skorska, Margaret / Piwocka, Katarzyna / Skorski, Tomasz et al. | 2019
- 265
-
An old misconception: Dutcher bodies are intranuclear inclusions in plasma cells?Han, Jae Ho / Cho, Sung Ran et al. | 2019
- 268
-
Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-bloodKristensen, Thomas / Broesby-Olsen, Sigurd / Vestergaard, Hanne / Bindslev-Jensen, Carsten / Mortz, Charlotte Gotthard / Kjaer, Henrik Fomsgaard / Møller, Michael Boe / on behalf of the Mastocytosis Centre Odense University Hospital (MastOUH) et al. | 2019
- 271
-
Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantationMori, Yasuo / Yoshimoto, Goichi / Yuda, Jun-Ichiro / Hayashi, Masayasu / Odawara, Jun / Kuriyama, Takuro / Sugio, Takeshi / Miyawaki, Kohta / Kamezaki, Kenjiro / Kato, Koji et al. | 2019
- 274
-
Autologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual diseaseCapria, Saveria / Pepe, Sara / Trisolini, Silvia Maria / Testi, Anna Maria / Vitale, Antonella / De Propris, Maria Stefania / Della Starza, Irene / Elia, Loredana / Guarini, Anna / Chiaretti, Sabina et al. | 2019
- 277
-
T784C LNK gene polymorphism and the risk of myeloproliferative disordersOlkhovskiy, Igor A. / Gorbenko, Aleksey S. / Stolyar, Marina A. / Vasiliev, Evgeniy V. / Mikhalev, Mikhail A. / Tabakova, Kseniya A. et al. | 2019